{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:44:51Z","timestamp":1777884291879,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02301-7","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:20:41Z","timestamp":1774344041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A nomogram for predicting the disease-free survival of patients with pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Yao","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Ni","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ri-Sheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"11","key":"2301_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"key":"2301_CR2","doi-asserted-by":"crossref","unstructured":"Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Chon\u00e9 L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, C.J., O\u2019Callaghan C, Jouffroy-Zeller P, Rat D, Malka F, Castan, Bachet JB. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379(25):2395\u20132406.","DOI":"10.1056\/NEJMoa1809775"},{"issue":"15","key":"2301_CR3","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","volume":"25","author":"MJ Moore","year":"2007","unstructured":"Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25(15):1960\u20136.","journal-title":"J Clin Oncol"},{"issue":"18","key":"2301_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691\u2013703.","journal-title":"N Engl J Med"},{"key":"2301_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jbior.2017.11.007","volume":"68","author":"A Adamska","year":"2018","unstructured":"Adamska A, Elaskalani O, Emmanouilidi A, Kim M, Abdol Razak NB, Metharom P, Falasca M. Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. Adv Biol Regul. 2018;68:77\u201387.","journal-title":"Adv Biol Regul"},{"issue":"1","key":"2301_CR6","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1186\/s12885-025-15165-x","volume":"25","author":"K Li","year":"2025","unstructured":"Li K, Zhang R, Zhang J, Zhang Z, Wang K, Lu Y, Zhao Z, Chen Y, Ma S. The prognostic role of inflammation-based hematologic markers in stage I-III colorectal cancer: a retrospective analysis. BMC Cancer. 2025;25(1):1822.","journal-title":"BMC Cancer"},{"key":"2301_CR7","doi-asserted-by":"publisher","first-page":"1694587","DOI":"10.3389\/fonc.2025.1694587","volume":"15","author":"K Wang","year":"2025","unstructured":"Wang K, Zhang B, Li K, Zhang Z, Zeng X, Guan JM, Aldridge R, Whitmore E, Pan Y, Lau LY, Zhao Z, Chen Y. Novel immune-nutritional prognostic ratio predicts long-term survival in stage I-III colorectal cancer. Front Oncol. 2025;15:1694587.","journal-title":"Front Oncol"},{"issue":"10","key":"2301_CR8","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.4240\/wjgs.v16.i10.3142","volume":"16","author":"P Shayimu","year":"2024","unstructured":"Shayimu P, Awula M, Wang CY, Jiapaer R, Pan YP, Wu ZM, Chen Y, Zhao ZL. Serum nutritional predictive biomarkers and risk assessment for anastomotic leakage after laparoscopic surgery in rectal cancer patients. World J Gastrointest Surg. 2024;16(10):3142\u201354.","journal-title":"World J Gastrointest Surg"},{"issue":"21","key":"2301_CR9","doi-asserted-by":"publisher","first-page":"e71317","DOI":"10.1002\/cam4.71317","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, Bai M, Liu M, Zhang Z, Jiang C, Li K, Chen Y, Xu Y, Wu L. Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance. Cancer Med. 2025;14(21):e71317.","journal-title":"Cancer Med"},{"issue":"26","key":"2301_CR10","doi-asserted-by":"publisher","first-page":"109500","DOI":"10.3748\/wjg.v31.i26.109500","volume":"31","author":"S Ren","year":"2025","unstructured":"Ren S, Song LN, Zhao R, Tian Y, Wang ZQ. Serum exosomal hsa-let-7f-5p: A potential diagnostic biomarker for metastatic pancreatic cancer detection. World J Gastroenterol. 2025;31(26):109500.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"2301_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/hpb.12154","volume":"16","author":"CW Tzeng","year":"2014","unstructured":"Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Serum carbohydrate antigen 19\u2009\u2013\u20099 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford). 2014;16(5):430\u20138.","journal-title":"HPB (Oxford)"},{"issue":"12","key":"2301_CR12","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1245\/s10434-008-0134-5","volume":"15","author":"SK Maithel","year":"2008","unstructured":"Maithel SK, Maloney S, Winston C, G\u00f6nen M, D\u2019Angelica MI, Dematteo RP, Jarnagin WR, Brennan MF, Allen PJ. Preoperative CA 19\u2009\u2013\u20099 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2008;15(12):3512\u201320.","journal-title":"Ann Surg Oncol"},{"issue":"Pt 2","key":"2301_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1042\/bj3120329","volume":"312","author":"LC Yu","year":"1995","unstructured":"Yu LC, Yang YH, Broadberry RE, Chen YH, Chan YS, Lin M. Correlation of a missense mutation in the human Secretor alpha 1,2-fucosyltransferase gene with the Lewis(a\u2009+\u2009b+) phenotype: a potential molecular basis for the weak Secretor allele (Sew). Biochem J. 1995;312(Pt 2):329\u201332.","journal-title":"Biochem J"},{"key":"2301_CR14","doi-asserted-by":"crossref","unstructured":"Boone BA, Steve J, Zenati MS, Hogg ME, Singhi AD, Bartlett DL, Zureikat AH, Bahary N, Zeh HJ 3. Serum CA 19\u2009\u2013\u20099 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinoma. Ann Surg Oncol. 2014;21(13):4351\u20138.","DOI":"10.1245\/s10434-014-3842-z"},{"issue":"7","key":"2301_CR15","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s11605-016-3149-4","volume":"20","author":"JL Williams","year":"2016","unstructured":"Williams JL, Kadera BE, Nguyen AH, Muthusamy VR, Wainberg ZA, Hines OJ, Reber HA, Donahue TR. CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer. J Gastrointest Surg. 2016;20(7):1331\u201342.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"2301_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","volume":"261","author":"CR Ferrone","year":"2015","unstructured":"Ferrone CR, Marchegiani G, Hong TS, Ryan DP, Deshpande V, McDonnell EI, Sabbatino F, Santos DD, Allen JN, Blaszkowsky LS, Clark JW, Faris JE, Goyal L, Kwak EL, Murphy JE, Ting DT, Wo JY, Zhu AX, Warshaw AL, Lillemoe KD. Fern\u00e1ndez-del Castillo, Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg. 2015;261(1):12\u20137.","journal-title":"Ann Surg"},{"issue":"1","key":"2301_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2016151289","volume":"280","author":"HJ Lee","year":"2016","unstructured":"Lee HJ, Im DJ, Youn JC, Chang S, Suh YJ, Hong YJ, Kim YJ, Hur J, Choi BW. Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging. Radiology. 2016;280(1):49\u201357.","journal-title":"Radiology"},{"issue":"4","key":"2301_CR18","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1172\/JCI73455","volume":"124","author":"EJ Koay","year":"2014","unstructured":"Koay EJ, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Bhosale PR, Tamm EP, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Varadhachary GR, Ferrari M, Fleming JB. Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest. 2014;124(4):1525\u201336.","journal-title":"J Clin Invest"},{"issue":"3","key":"2301_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2214\/AJR.19.22462","volume":"215","author":"ZJ Wang","year":"2020","unstructured":"Wang ZJ, Zhang TT, An C, Ko AH, Tempero M, Collisson E, Yeh BM. Estimation of Fractional Extracellular Space at CT for Predicting Chemotherapy Response and Survival in Pancreatic Ductal Adenocarcinoma. AJR Am J Roentgenol. 2020;215(3):610\u20136.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2301_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11596-022-2535-2","volume":"42","author":"S Ren","year":"2022","unstructured":"Ren S, Tang HJ, Zhao R, Duan SF, Chen R, Wang ZQ. Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma. Curr Med Sci. 2022;42(1):217\u201325.","journal-title":"Curr Med Sci"},{"issue":"8","key":"2301_CR21","doi-asserted-by":"publisher","first-page":"109373","DOI":"10.4329\/wjr.v17.i8.109373","volume":"17","author":"S Ren","year":"2025","unstructured":"Ren S, Qin B, Daniels MJ, Zeng L, Tian Y, Wang ZQ. Developing and validating a computed tomography radiomics strategy to predict lymph node metastasis in pancreatic cancer. World J Radiol. 2025;17(8):109373.","journal-title":"World J Radiol"},{"key":"2301_CR22","doi-asserted-by":"publisher","first-page":"b375","DOI":"10.1136\/bmj.b375","volume":"338","author":"KG Moons","year":"2009","unstructured":"Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375.","journal-title":"BMJ"},{"issue":"24","key":"2301_CR23","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1200\/JCO.2005.05.3884","volume":"24","author":"BH Bochner","year":"2006","unstructured":"Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;24(24):3967\u201372.","journal-title":"J Clin Oncol"},{"issue":"30","key":"2301_CR24","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1200\/JCO.2005.01.8101","volume":"23","author":"CR Ferrone","year":"2005","unstructured":"Ferrone CR, Kattan MW, Tomlinson JS, Thayer SP, Brennan MF, Warshaw AL. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005;23(30):7529\u201335.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2301_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1001\/archsurg.2008.580","volume":"144","author":"JB Fleming","year":"2009","unstructured":"Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg. 2009;144(3):216\u201321.","journal-title":"Arch Surg"},{"issue":"2","key":"2301_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jpainsymman.2011.09.010","volume":"44","author":"S Dalal","year":"2012","unstructured":"Dalal S, Hui D, Bidaut L, Lem K, Del Fabbro E, Crane C, Reyes-Gibby CC, Bedi D, Bruera E. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manage. 2012;44(2):181\u201391.","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"2301_CR27","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1245\/s10434-012-2809-1","volume":"20","author":"W Hartwig","year":"2013","unstructured":"Hartwig W, Strobel O, Hinz U, Fritz S, Hackert T, Roth C, B\u00fcchler MW, Werner J. CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol. 2013;20(7):2188\u201396.","journal-title":"Ann Surg Oncol"},{"key":"2301_CR28","doi-asserted-by":"crossref","unstructured":"Thiele CM, Kolmer A, Response to Comment on Conformational analysis of small organic molecules using NOE and RDC data: A discussion of strychnine and \u03b1-methylene-\u03b3-butyrolactone by, Khodov IA, Kiselev MG, Klochkov VV, Efimov SV. [http:\/\/dx.doi.org\/10.1016\/j.jmr.2016.02.009] - Or Life is about compromises. J Magn Reson. 2016;266:69\u201372.","DOI":"10.1016\/j.jmr.2016.02.010"},{"issue":"7","key":"2301_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.hpb.2018.01.001","volume":"20","author":"E van Veldhuisen","year":"2018","unstructured":"van Veldhuisen E, Vogel JA, Klompmaker S, Busch OR, van Laarhoven HWM, van Lienden KP, Wilmink JW, Marsman HA, Besselink MG. Added value of CA19-9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy. HPB (Oxford). 2018;20(7):605\u201311.","journal-title":"HPB (Oxford)"},{"issue":"4","key":"2301_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ejrad.2013.12.016","volume":"83","author":"Y Fukukura","year":"2014","unstructured":"Fukukura Y, Takumi K, Higashi M, Shinchi H, Kamimura K, Yoneyama T, Tateyama A. Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma. Eur J Radiol. 2014;83(4):612\u20139.","journal-title":"Eur J Radiol"},{"issue":"3","key":"2301_CR31","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1148\/radiol.2019182561","volume":"292","author":"A Hamdy","year":"2019","unstructured":"Hamdy A, Ichikawa Y, Toyomasu Y, Nagata M, Nagasawa N, Nomoto Y, Sami H, Sakuma H. Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience. Radiology. 2019;292(3):628\u201335.","journal-title":"Radiology"},{"issue":"1","key":"2301_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/radiol.10100015","volume":"257","author":"JH Kim","year":"2010","unstructured":"Kim JH, Park SH, Yu ES, Kim MH, Kim J, Byun JH, Lee SS, Hwang HJ, Hwang JY, Lee SS, Lee MG. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257(1):87\u201396.","journal-title":"Radiology"},{"issue":"6","key":"2301_CR33","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ejso.2017.03.015","volume":"43","author":"H Akita","year":"2017","unstructured":"Akita H, Takahashi H, Ohigashi H, Tomokuni A, Kobayashi S, Sugimura K, Miyoshi N, Moon JH, Yasui M, Omori T, Miyata H, Ohue M, Fujiwara Y, Yano M, Ishikawa O, Sakon M. FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Eur J Surg Oncol. 2017;43(6):1061\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"2301_CR34","doi-asserted-by":"crossref","unstructured":"Ahuja M, Pand\u00e9 R, Chugtai S, Brown RM, Cain O, Bartlett DC, Dasari BVM, Marudanayagam R, Roberts KJ, Isaac J, Sutcliffe RP, Chatzizacharias N. Vein wall invasion is a more reliable predictor of oncological outcomes than vein-related margins after pancreaticoduodenectomy for early stages of pancreatic ductal adenocarcinoma. Diagnostics (Basel). 2023;13(22).","DOI":"10.3390\/diagnostics13223465"},{"key":"2301_CR35","doi-asserted-by":"publisher","first-page":"1074445","DOI":"10.3389\/fonc.2023.1074445","volume":"13","author":"X Xu","year":"2023","unstructured":"Xu X, Qu J, Zhang Y, Qian X, Chen T, Liu Y. Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma. Front Oncol. 2023;13:1074445.","journal-title":"Front Oncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02301-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02301-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02301-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:20:01Z","timestamp":1777602001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02301-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2301"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02301-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local institutional review board from The Second Affiliated Hospital of Zhejiang University and informed consent was waived according to the retrospective design. All procedures performed in studies were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"227"}}